Acrivon Therapeutics (ACRV proposed), a cancer biotech aiming to raise $100.3 million, leads a life sciences-focused IPO Calendar of seven deals during this election week. This is the first big IPO ($100 million-plus) to land on the IPO Calendar since Mobileye Global, Inc. (MBLY) scored its successful IPO in late October. Four of this week’s seven deals are from […]
November 6, 2022 Read MoreAcrivon Therapeutics (ACRV proposed), a cancer biotech, filed terms – 5.9 million shares at $16.00 to $18.00 – early today (Thursday, Nov. 3, 2022) and landed on next week’s IPO Calendar. The deal, which will raise $100.3 million if priced at the $17.00 mid-point, launched today as well. It’s set to price on Wednesday night, […]
November 3, 2022 Read MoreAfter Mobileye (MBLY), what’s next? So far, only three tiny deals – two IPOs and a NASDAQ uplisting – are on the IPO Calendar this week. With Halloween falling on Monday this year, maybe IPO bankers had the right idea to not schedule any deals for pricing after the close. (Editor’s Note: This column, published on […]
October 31, 2022 Read MoreMobileye Global, Inc. (MBLY) raced onto the IPO freeway – running up 37.95 percent to close at $28.97 today – its first day of NASDAQ trading. Volume: 27,929,867 shares. The stock roared out of the gate – rising 27.2 percent to $26.71 in its opening trade today (Oct. 26, 2022) on the NASDAQ on volume of […]
October 25, 2022 Read MoreMobileye Global (MBLY proposed), Intel’s self-driving car unit, is ready to cruise onto the IPO freeway this week with its $779 million deal – one of the most highly anticipated IPOs of the year. Mobileye’s IPO – 41.0 million shares at $18.00 to $20.00 – is set for pricing Tuesday night (Oct. 25, 2022) to trade […]
October 23, 2022 Read MoreTalk about a healthy start. Prime Medicine, Inc. (PRME) started NASDAQ trading shortly after noon EDT today at $18.97 – up $1.97 or 11.6 percent from its $17.00 IPO price. The first trade occurred at 12:11 p.m. EDT on volume of 532,337 shares, NASDAQ records show. By early afternoon, though, the stock gave up its early […]
October 20, 2022 Read MoreMobileye Global (MBLY proposed), Intel’s self-driving car unit, stepped on the gas early today – filing terms for its highly anticipated IPO – to give the Israeli company a valuation of about $15.13 billion. That’s a hair less than what Intel paid for Mobileye in 2017. Mobileye’s S-1/A filing popped through the SEC’s filing window […]
October 18, 2022 Read MoreMomentum may be the word of the day. Prime Medicine, Inc. (PRME proposed) – a pre-clinical gene editing company – plans to raise $151.3 million this week. Mobileye Global (MBLY proposed), Intel’s self-driving car unit, may be up next. The Wall Street Journal reported late Monday (Oct. 17, 2022) that Mobileye is likely to cut […]
October 17, 2022 Read MoreTwo SPAC IPOs wrapped up the second week of October: Hudson Acquisition I Corp. (HUDAU) started trading on the NASDAQ today (Friday, Oct. 14, 2022) at $10.01, up a penny from its SPAC IPO price – and ended the day at $10.01. TenX Keane Acquisition (TENKU) also began NASDAQ trading today – opening at $10.04 – and […]
October 13, 2022 Read MoreAquaron Acquisition Corp. (AQUNU) priced its SPAC IPO – 5 million units at $10.00 each – on Monday night (Oct. 3, 2022) – to get the IPO machinery in gear for October. Aquaron’s IPO officially began trading on the NASDAQ at 11:10 a.m. EDT today (Tuesday, Oct. 4, 2022) at $10.00 – flat with its […]
October 4, 2022 Read More